Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,944 | 30,591 | -16,240 | -14,940 | -32,570 |
| Depreciation Amortization | 3,739 | 2,150 | 1,083 | 5,920 | 6,500 |
| Accounts receivable | -3,930 | 1,329 | -3,650 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,829 | 190 | 81 | N/A | N/A |
| Other Working Capital | 41,650 | 43,032 | -1,159 | 31,790 | 16,260 |
| Other Operating Activity | 11,835 | -54 | 4,364 | 3,140 | 4,210 |
| Operating Cash Flow | $46,179 | $77,238 | $-15,521 | $25,910 | $-5,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,542 | -3,952 | -2,331 | -6,800 | -740 |
| Sale Of Investment | 38,546 | 33,546 | 14,546 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 17,570 | 19,890 |
| Investing Cash Flow | $33,004 | $29,594 | $12,215 | $10,770 | $19,150 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -302 | -201 | -101 | N/A | N/A |
| Common Stock Issued | 925 | 831 | 37 | N/A | N/A |
| Other Financing Activity | -2,194 | -1,167 | 0 | 680 | 6,800 |
| Financing Cash Flow | $-1,571 | $-537 | $-64 | $680 | $6,800 |
| Exchange Rate Effect | -55 | 35 | -9 | 80 | -60 |
| Beginning Cash Position | 76,332 | 76,332 | 76,332 | 38,870 | 18,580 |
| End Cash Position | 153,889 | 182,662 | 72,953 | 76,330 | 38,870 |
| Net Cash Flow | $77,557 | $106,330 | $-3,379 | $37,460 | $20,280 |
| Free Cash Flow | |||||
| Operating Cash Flow | 46,179 | 77,238 | -15,521 | 25,910 | -5,600 |
| Capital Expenditure | -5,542 | -3,952 | -2,331 | N/A | N/A |
| Free Cash Flow | 40,637 | 73,286 | -17,852 | 25,910 | -5,600 |